Tumor immune microenvironment in pituitary neuroendocrine tumors (PitNETs): increased M2 macrophage infiltration and PD-L1 expression in PIT1-lineage subset

被引：0

作者：

Mei Luo

Rui Tang

Haijun Wang

机构：

[1] Sun Yat-Sen University,Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital

[2] Central South University,Department of Rheumatology and Immunology, The Second Xiangya Hospital

来源：

Journal of Neuro-Oncology | 2023年 / 163卷

关键词：

PitNETs; PIT1; M2-macrophage; PD-L1; Immunotherapy;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：663 / 674

页数：11

共 50 条

[21] Clear cell ovarian cancers with microsatellite instability: A unique subset of ovarian cancers with increased tumor-infiltrating lymphocytes and PD-1/PD-L1 expression
Howitt, Brooke E.
Strickland, Kyle C.
Sholl, Lynette M.
Rodig, Scott
Ritterhouse, Lauren L.
Chowdhury, Dipanjan
D'Andrea, Alan D.
Matulonis, Ursula A.
Konstantinopoulos, Panagiotis A.
ONCOIMMUNOLOGY, 2017, 6 (02):
[22] MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression
Lin, Jinti
Xu, Ankai
Jin, Jiakang
Zhang, Man
Lou, Jianan
Qian, Chao
Zhu, Jian
Wang, Yitian
Yang, Zhengming
Li, Xiumao
Yu, Wei
Liu, Bing
Tao, Huimin
ONCOIMMUNOLOGY, 2022, 11 (01):
[23] CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
Wu, Xuehui
Lan, Xiaoliang
Hu, Wanming
Zhang, Wanning
Lai, Xiangmeng
Xu, Shaowan
Li, Jiaoying
Qiu, Weihao
Wang, Wei
Xiao, Jianbiao
Wang, Feifei
Ding, Yanqing
Liang, Li
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (11) : 3235 - 3248
[24] CMTM6 expression in M2 macrophages is a potential predictor of PD-1/PD-L1 inhibitor response in colorectal cancer
Xuehui Wu
Xiaoliang Lan
Wanming Hu
Wanning Zhang
Xiangmeng Lai
Shaowan Xu
Jiaoying Li
Weihao Qiu
Wei Wang
Jianbiao Xiao
Feifei Wang
Yanqing Ding
Li Liang
Cancer Immunology, Immunotherapy, 2021, 70 : 3235 - 3248
[25] Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high grade leiomyosarcomas supports immunotherapeutic strategies
Kostine, Marie
Briaire-de Bruijn, Inge H.
Cleven, Arjen H. G.
Vervat, Carly
Corver, Willem E.
Schilham, Marco W.
Van Beelen, Els
van Boven, Hester
Haas, Rick L.
Italiano, Antoine
Cleton-Jansen, Anne-Marie
Bovee, Judith V. M. G.
ONCOIMMUNOLOGY, 2018, 7 (02):
[26] Differences in PD-L1 expression on tumor and immune cells between lung metastases and corresponding primary tumors
Takamori, Shinkichi
Takada, Kazuki
Tagawa, Tetsuzo
Toyokawa, Gouji
Hirai, Fumihiko
Yamashita, Nami
Okamoto, Tatsuro
Oki, Eiji
Yoshizumi, Tomoharu
Od, Yoshinao
Maehara, Yoshihiko
SURGICAL ONCOLOGY-OXFORD, 2018, 27 (04): : 637 - 641
[27] Characterizing the immune microenvironment of malignant peripheral nerve sheath tumor by PD-L1 expression and presence of CD8+tumor infiltrating lymphocytes
Shurell, Elizabeth
Singh, Arun S.
Crompton, Joseph G.
Jensen, Sarah
Li, Yunfeng
Dry, Sarah
Nelson, Scott
Chmielowski, Bartosz
Bernthal, Nicholas
Federman, Noah
Tumeh, Paul
Eilber, Fritz C.
ONCOTARGET, 2016, 7 (39) : 64300 - 64308
[28] Shikonin inhibits immune checkpoint PD-L1 expression on macrophage in sepsis by modulating PKM2
Yuan, Lijia
Wang, Yong
Chen, Youlian
Chen, Xiaoyin
Li, Shun
Liu, Xueyan
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 121
[29] Co-expression of NGF and PD-L1 on tumor-associated immune cells in the microenvironment of Merkel cell carcinoma
Wehkamp, Ulrike
Stern, Sophie
Krueger, Sandra
Weichenthal, Michael
Hauschild, Axel
Roecken, Christoph
Egberts, Friederike
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (07) : 1301 - 1308
[30] Characteristics of the immune microenvironment associated with RRM2 expression and its application to PD-L1/PD-1 inhibitors in lung adenocarcinoma
Lee, Seul-Ki
Hwang, Yoonjung
Han, Jae-Ho
Haam, Seokjin
Lee, Hyun Woo
Koh, Young Wha
AMERICAN JOURNAL OF CANCER RESEARCH, 2023, 13 (11): : 5443 - +

← 1 2 3 4 5 →